M. Kathleen Behrens - Jun 30, 2021 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Director
Signature
/s/ Misbah Tahir, by power of attorney
Stock symbol
IGMS
Transactions as of
Jun 30, 2021
Transactions value $
$0
Form type
4
Date filed
7/2/2021, 08:04 PM
Previous filing
May 28, 2021
Next filing
Oct 4, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $0 +211 +12.87% $0.00 1.85K Jun 30, 2021 Direct F1, F2
holding IGMS Common Stock 115K Jun 30, 2021 See footnote F2, F3
holding IGMS Common Stock 21.1K Jun 30, 2021 See footnote F4
holding IGMS Common Stock 21.1K Jun 30, 2021 See footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy.
F2 Pursuant to an internal review, the number of shares beneficially owned has been adjusted to correct the number of shares owned directly as compared to the number of shares held by the KBW 2005 Trust for which Reporting Person is Trustee (the "KBW 2005 Trust"). Other than the acquisition of restricted stock units reported in this Form 4, the total number of shares held by the Reporting Person has not changed.
F3 The shares are held in the name of KBW 2005 Trust.
F4 The shares are held in the name of Non-Exempt Trust for Patrick R. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee.
F5 The shares are held in the name of Non-Exempt Trust for Shannon K. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee.